You are here

Home News and Events

News and Events

Research centre lobby

For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page. 

Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT). 

Date1 Press Release
28 September 2016 CRT Pioneer Fund Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) to ProNAi Read more
21 September 2016 CRT and SV life sciences form Artios Pharma to focus on DNA damage response Read more
9 August 2016 CRT and Alta Innovations join forces to commercialise world-leading research Read more
26 May 2016 Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs Read more
22 April 2016 CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer Read more
27 January 2016 CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders Read more
12 January 2016 FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets Read more
6 January 2016 Cancer Research Technology, Cell Therapy Catapult and University of Birmingham launch new collaboration for CAR-T cell immuno-oncology therapy development Read more
9 December 2015 Cancer Research Technology appoints Deborah Harland as Non-Executive Director Read more
7 December 2015 Nemucore Medical Innovations options clinical-stage Aurora Kinase Inhibitor GSK1070916 from CRT Read more

Pages